Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of levofloxacin in bone
2007-003898-42Phase 4Active
- Sponsor
- Institute of Pharmacology and Toxicology
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levofloxacin in osteomyelitis (OM), sponsored by Institute of Pharmacology and Toxicology. Primary endpoints: Bone and plasma levofloxacin concentrations and Criteria for development of improved antibiotics for bone infection prophylaxis. Started Oct 2007; status: active.
02
Drugs
levofloxacin
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on 2007-003898-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003898-42.